Chronic myeloid leukemia (CML) stem cells were found to be maintained by dipeptides accumulated via upregulated expression of Slc15A2 dipeptide transporters (165). The gene discussed is SLC15A2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.